Abstract 1863P
Background
A descriptive, cross-sectional, multicenter study was carried out among the nursing staff working in several departments caring for cancer patients (Carcinology Sousse, Monastir, Sfax, Institut Salah Azaiez and Ariana).
Methods
The instrument used to measure CE was the "Professional quality of life" (PRO-QOL version5), which is composed of 3 subscales: 10 items to measure compassion satisfaction (SC), 10 items to measure professional exhaustion (PE) and 10 items to measure secondary traumatic stress (STS).
Results
A total of 120 health personnel responded to the questionnaire. The average age of the participants was 36.13±8.06 with a clear female predominance (sex ratio=0.29). Most respondents were physicians (55.9%). The mean CS score was 33.57±6.24, which is consistent with an average level of CS. However, 13.3% of the staff had a high SC score. The mean PE score was 29.88±5.12, which corresponds to an average level of PE. Only 10.9% had a low PE score. The mean STS score was 33.16±7.56, which corresponds to an average level of STS. However, 17.5% had a high STS score.
Conclusions
Compassion fatigue can lead to real burnout. Its prevention, detection and implementation of solutions to stem the process is essential.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
1-Service of carcinological medicine CHU FarhatHached Sousse 2- Hospital hygiene service CHU FarhatHached Sousse 1-Service of carcinological medicine CHU FarhatHached Sousse 2- Hospital hygiene service CHU FarhatHached Sousse Service of carcinological medicine CHU FarhatHached Sousse and Hospital hygiene service CHU FarhatHached Sousse.
Funding
Has not received any funding.
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
2018P - Novel nomogram based on the expression of DLL3 and PD-L1 for predicting the prognosis of small cell lung cancer patients
Presenter: Jun Zhao
Session: Poster session 05
2019P - Analysis of lung immune prognostic index (LIPI) score in a small cell lung cancer carcinoma (SCLC) cohort, supporting its prognostic use and investigating its predictive potential
Presenter: Mónica Esteban García
Session: Poster session 05
2020P - Circulating micro RNAs (cmiRNAs) as treatment outcome predictors in extensive small cell lung cancer (eSCLC) patients (pts) receiving atezolizumab plus carboplatin and etoposide (ACE): CATS/ML43257 study
Presenter: Giulia Pasello
Session: Poster session 05
2021P - Cell-free (cf) DNA as predictive biomarker (B) of treatment outcome in extensive small cell lung cancer (eSCLC) patients (pts) receiving atezolizumab, carboplatin and etoposide (ACE): CATS/ML43257 study
Presenter: Giulia Pasello
Session: Poster session 05
2022P - ALBA project: Prognostic impact of laterality in small cell lung cancer
Presenter: Lorenza Landi
Session: Poster session 05
2024P - Supportive measures to control myelosuppression and costs for patients with SCLC with lurbinectedin, CAV or topotecan with or without trilaciclib: A review on the basis of clinical trials
Presenter: Manuel Dómine
Session: Poster session 05
2025P - Stratified control study of neuroendocrine differentiation and potential clinicopathologic markers
Presenter: Li Liu
Session: Poster session 05
2026P - Small cell lung cancer (SCLC) in the KBP-2020-CPHG cohort and comparison with 2000 and 2010
Presenter: Lionel Falchero
Session: Poster session 05
2027P - Immune checkpoint inhibitors in the treatment of small cell lung cancer: A systematic review and meta-analysis
Presenter: Patsy Lee
Session: Poster session 05